Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about EIF2A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
EIF2A is a protein involved in neurodegeneration research. Key relationships include: interacts with, activates, inhibits. Associated with ALS, Aging, Als. Connected to 296 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | EIF2A |
| Full Name | Eukaryotic Translation Initiation Factor 2A |
| Chromosome | 3q27.1 |
| Function | Binds the 40S ribosomal subunit |
| Pathways | Akt, Apoptosis, Er Stress, Wnt |
| UniProt ID | Q9Y5Q3 |
| NCBI Gene ID | 27185 |
| Ensembl ID | ENSG00000144895 |
| OMIM | 609994 |
| GeneCards | EIF2A |
| Human Protein Atlas | EIF2A |
| Associated Diseases | neurodegeneration |
| Known Drugs/Compounds | rapamycin |
| Interactions | Actin, AKT, AKT1, AKT1S1, ALS, ALZHEIMER |
| KG Connections | 533 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
EIF2A["EIF2A"] -->|"regulates"| stress_granules["stress granules"]
EIF2A["EIF2A"] -->|"interacts"| Cancer["Cancer"]
EIF2A["EIF2A"] -->|"interacts"| Als["Als"]
EIF2A["EIF2A"] -->|"interacts"| Ms["Ms"]
EIF2A["EIF2A"] -->|"interacts"| Fibrosis["Fibrosis"]
EIF2A["EIF2A"] -->|"interacts"| Aging["Aging"]
OPTN["OPTN"] -->|"interacts"| EIF2A["EIF2A"]
CASP3["CASP3"] -->|"interacts"| EIF2A["EIF2A"]
AKT1["AKT1"] -->|"interacts"| EIF2A["EIF2A"]
CALCOCO2["CALCOCO2"] -->|"interacts"| EIF2A["EIF2A"]
style EIF2A fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| protein synthesis | regulates | process | 0.90 |
| Protein Translation | regulates | process | 0.85 |
| Endoplasmic Reticulum Stress | involved_in | process | 0.85 |
| autophagy pathway | participates_in | pathway | 0.80 |
| Als | activates | disease | 0.75 |
| Endoplasmic Reticulum Stress | biomarker_for | process | 0.75 |
| stress granules | regulates | process | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| Cancer | regulates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Heart Failure | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Cancer | interacts_with | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Fibrosis | interacts_with | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Aging | interacts_with | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Fibrosis | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| ALS | interacts_with | disease | 0.65 |
| Traumatic Brain Injury | activates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Ischemia | interacts_with | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Als | contributes_to | disease | 0.65 |
| Inflammation | interacts_with | disease | 0.65 |
| BCL-2 | expressed_in | gene | 0.60 |
| Apoptosis | regulates | pathway | 0.60 |
| NEURODEGENERATIVE DISEASES | inhibits | gene | 0.60 |
| ATG | activates | gene | 0.60 |
| INFLAMMATION | interacts_with | gene | 0.60 |
| Angiogenesis | interacts_with | pathway | 0.60 |
| Immune Response | interacts_with | pathway | 0.60 |
| Pi3K/Akt | activates | pathway | 0.60 |
| Stem Cell | interacts_with | cell_type | 0.60 |
| Epithelial | interacts_with | cell_type | 0.60 |
| Dendritic Cell | interacts_with | cell_type | 0.60 |
| DNA | activates | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| MAP1LC3 | activates | gene | 0.60 |
| TAR | activates | gene | 0.60 |
| frontotemporal dementia | activates | disease | 0.60 |
| ubiquitin-proteasome | participates_in | pathway | 0.60 |
| TFEB | activates | gene | 0.60 |
| Akt | contributes_to | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| TMTD | phosphorylates | compound | 0.90 |
| DTG | upregulates | drug | 0.85 |
| PERK | phosphorylates | protein | 0.85 |
| Stress Granules | phosphorylates | process | 0.85 |
| rapamycin | targets | drug | 0.70 |
| CYP1A1 | activates | gene | 0.60 |
| ALS | activates | gene | 0.60 |
| RICTOR | interacts_with | gene | 0.60 |
| MAP1LC3A | interacts_with | gene | 0.60 |
| LC3 | interacts_with | gene | 0.60 |
| MAVS | interacts_with | gene | 0.60 |
| EGFR | interacts_with | gene | 0.60 |
| RPTOR | interacts_with | gene | 0.60 |
| LRRK2 | interacts_with | gene | 0.60 |
| MITOPHAGY | inhibits | gene | 0.60 |
| RB1CC1 | interacts_with | gene | 0.60 |
| APC | interacts_with | gene | 0.60 |
| RIPK1 | interacts_with | gene | 0.60 |
| MAPK14 | interacts_with | gene | 0.60 |
| MLKL | interacts_with | gene | 0.60 |
| DDIT3 | phosphorylates | entity | 0.60 |
| DEPTOR | phosphorylates | entity | 0.60 |
| EGF | phosphorylates | entity | 0.60 |
| EGFR | phosphorylates | entity | 0.60 |
| EGF | activates | gene | 0.60 |
| ATG16L1 | interacts_with | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | inhibits | gene | 0.60 |
| ATG | interacts_with | gene | 0.60 |
| CDH1 | interacts_with | gene | 0.60 |
| GENES | interacts_with | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| PHGDH | activates | gene | 0.60 |
| ROS | interacts_with | gene | 0.60 |
| DNA | interacts_with | gene | 0.60 |
| LYSOSOME | interacts_with | gene | 0.60 |
| MTORC1 | interacts_with | gene | 0.60 |
| CANCER | interacts_with | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| BRAIN INJURY | activates | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| CANCER | phosphorylates | entity | 0.60 |
| WNT | interacts_with | gene | 0.60 |
| NLR | interacts_with | gene | 0.60 |
| IFN | interacts_with | gene | 0.60 |
| MAPK | interacts_with | gene | 0.60 |
| NRBF2 | interacts_with | gene | 0.60 |
| GABARAP | associated_with | gene | 0.60 |
| ATF4 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning EIF2A in their description or question text
No additional research found